Search research articles
Contact Us
Filters
Showing results (1-10 of 250) with videos related to
Page
of 25
Sort By:
Cytokines and Molecular Therapy
|
September 1, 1996
Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transduction
S Salvadori, K Zier
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
November 24, 1999
Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A
S Capasso, S Salvadori
Il Farmaco; Edizione Scientifica
|
August 1, 1977
N-terminal Leu-enkephalin rearrangements
R Tomatis, S Salvadori
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2
S Salvadori, K Zier
Cancer Immunology, Immunotherapy : CII
|
September 9, 1999
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2
K S Zier, S Salvadori
Pharmacological Research
|
May 1, 1990
Interaction of FCE 22176, a stable prostacyclin analogue, with different prostaglandins in guinea-pig trachea and atria
E Ragazzi, S Salvadori, G Froldi
Arzneimittel-Forschung
|
January 1, 1984
Pharmacological studies of a series of dermorphin related pentapeptides
S Salvadori, G Sarto, R Tomatis
International Journal of Peptide and Protein Research
|
May 1, 1982
Synthesis and pharmacological activity of dermorphin and its N-terminal sequences
S Salvadori, G Sarto, R Tomatis
Cancer Gene Therapy
|
September 1, 1994
Functional defects are associated with abnormal signal transduction in T cells of mice inoculated with parental but not IL-2 secreting tumor cells
S Salvadori, B Gansbacher, K Zier
Il Farmaco; Edizione Scientifica
|
October 1, 1982
Opioid peptide. Structure-activity relationships in dermorphin tetrapeptide-amides. II
S Salvadori, R Tomatis, G Sarto
Page
of 25
Search research articles
Search
Showing results (1-10 of 250) with videos related to
Sort By:
Page
of 25
Cytokines and Molecular Therapy
|
September 1, 1996
Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transduction
S Salvadori, K Zier
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
November 24, 1999
Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A
S Capasso, S Salvadori
Il Farmaco; Edizione Scientifica
|
August 1, 1977
N-terminal Leu-enkephalin rearrangements
R Tomatis, S Salvadori
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2
S Salvadori, K Zier
Cancer Immunology, Immunotherapy : CII
|
September 9, 1999
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2
K S Zier, S Salvadori
Pharmacological Research
|
May 1, 1990
Interaction of FCE 22176, a stable prostacyclin analogue, with different prostaglandins in guinea-pig trachea and atria
E Ragazzi, S Salvadori, G Froldi
Arzneimittel-Forschung
|
January 1, 1984
Pharmacological studies of a series of dermorphin related pentapeptides
S Salvadori, G Sarto, R Tomatis
International Journal of Peptide and Protein Research
|
May 1, 1982
Synthesis and pharmacological activity of dermorphin and its N-terminal sequences
S Salvadori, G Sarto, R Tomatis
Cancer Gene Therapy
|
September 1, 1994
Functional defects are associated with abnormal signal transduction in T cells of mice inoculated with parental but not IL-2 secreting tumor cells
S Salvadori, B Gansbacher, K Zier
Il Farmaco; Edizione Scientifica
|
October 1, 1982
Opioid peptide. Structure-activity relationships in dermorphin tetrapeptide-amides. II
S Salvadori, R Tomatis, G Sarto
Page
of 25